Eileen S Debbi, MD | |
164-05 Hillside Avenue, Jamaica, NY 11432-4140 | |
(718) 297-6090 | |
(718) 297-6094 |
Full Name | Eileen S Debbi |
---|---|
Gender | Female |
Speciality | Specialist |
Location | 164-05 Hillside Avenue, Jamaica, New York |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326076589 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2081P2900X | Physical Medicine & Rehabilitation - Pain Medicine | 169637 (New York) | Secondary |
174400000X | Specialist | 169637 (New York) | Primary |
Entity Name | Hillside Medical & Pain Management, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548299910 PECOS PAC ID: 3779550355 Enrollment ID: O20040914000027 |
News Archive
Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that its CE Mark Clinical Trial for HeartMate III™ commenced with the first patient implanted with this new device.
With the overhaul continuing to be a divisive issue, lawmakers from both sides of the aisle - as well as the measure's advocates and opponents - have put in place messages and plans to keep their arguments strong.
Nosopharm, a specialist in the research and development of new anti-infective drugs, announces today its in vitro and in vivo findings for a novel antibacterial class, Odilorhabdins, which has the potential to combat antibiotic resistance.
A firm reassurance that training places for future GPs will be resourced was given today (22/09/04) by English Health Minister John Hutton speaking at a GP Recruitment conference at the BMA.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Eileen S Debbi, MD 164-05 Hillside Avenue, Jamaica, NY 11432-4140 Ph: (718) 297-6090 | Eileen S Debbi, MD 164-05 Hillside Avenue, Jamaica, NY 11432-4140 Ph: (718) 297-6090 |
News Archive
Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that its CE Mark Clinical Trial for HeartMate III™ commenced with the first patient implanted with this new device.
With the overhaul continuing to be a divisive issue, lawmakers from both sides of the aisle - as well as the measure's advocates and opponents - have put in place messages and plans to keep their arguments strong.
Nosopharm, a specialist in the research and development of new anti-infective drugs, announces today its in vitro and in vivo findings for a novel antibacterial class, Odilorhabdins, which has the potential to combat antibiotic resistance.
A firm reassurance that training places for future GPs will be resourced was given today (22/09/04) by English Health Minister John Hutton speaking at a GP Recruitment conference at the BMA.
› Verified 5 days ago